Related Experiment Video
Updated: Jun 7, 2025

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
DRAMP 4.0: an open-access data repository dedicated to the clinical translation of antimicrobial peptides
Tianyue Ma1, Yanchao Liu1, Bingxin Yu1
1School of Life Science and Technology, China Pharmaceutical University, Nanjing 211100, P.R. China.
Abstract:
Antimicrobial peptides (AMPs) are potential candidates for treating multidrug-resistant bacterial infections, yet only a small number of them have progressed into clinical trials. The main challenges include the poor stability and hemolytic/cytotoxic properties of AMPs. Considering this, in the update of the Data Repository of Antimicrobial Peptides (DRAMP), a new annotation on serum and protease stability is added, and special efforts were made to update the hemolytic/cytotoxic information of AMPs. The DRAMP 4.0 currently holds 30 260 entries (8 001 newly added), consisting of 11 612 general entries, 17 886 patent entries, 96 clinical entries, 377 specific entries, 110 entries with stability data, and 179 expanded entries. A total of 2891 entries possess experimentally determined hemolytic activity information, while 2674 entries contain cytotoxicity data by experimental validation. The update also covers new annotations, statistics, categories, functions, and download links. DRAMP is available online at http://dramp.cpu-bioinfor.org/.
Insights
The Data Repository of Antimicrobial Peptides (DRAMP) 4.0 now includes crucial stability and toxicity data for antimicrobial peptides (AMPs). This update aims to overcome challenges in developing AMPs for multidrug-resistant infections.
Area of Science:
- Biochemistry
- Pharmacology
- Bioinformatics
Background:
- Antimicrobial peptides (AMPs) show promise for treating multidrug-resistant bacterial infections.
- Clinical progression of AMPs is hindered by poor stability and hemolytic/cytotoxic properties.
Purpose of the Study:
- To update the Data Repository of Antimicrobial Peptides (DRAMP) with enhanced stability and toxicity data.
- To facilitate the development of safer and more effective AMPs.
Main Methods:
- Incorporated new annotations for serum and protease stability.
- Updated hemolytic and cytotoxic information based on experimental validation.
- Expanded the DRAMP database with new entries and categories.
Main Results:
- DRAMP 4.0 contains 30,260 entries, including 8,001 new additions.
- Detailed experimental data on hemolytic activity (2,891 entries) and cytotoxicity (2,674 entries) are now available.
- The repository includes stability data for 110 entries and expanded entries for 179 peptides.
Conclusions:
- DRAMP 4.0 provides a comprehensive resource for AMP research, addressing key challenges in their development.
- The updated data repository supports the identification and optimization of AMPs for therapeutic applications.
More Related Videos
07:49Creating and Applying a Reference to Facilitate the Discussion and Classification of Proteins in a Diverse Group
Published on: August 16, 2017
09:07Author Spotlight: Accelerating Diagnostic Accuracy with Direct Identification of Gram-Negatives from Blood Culture Bottles
Published on: May 24, 2024